Dominari Holdings Inc. (DOMH)
NASDAQ: DOMH · Real-Time Price · USD
3.900
-0.100 (-2.50%)
At close: Apr 1, 2025, 4:00 PM
3.890
-0.010 (-0.27%)
After-hours: Apr 1, 2025, 5:02 PM EDT
Dominari Holdings Market Cap
Dominari Holdings has a market cap or net worth of $55.91 million as of April 1, 2025. Its market cap has increased by 394.74% in one year.
Market Cap
55.91M
Enterprise Value
54.00M
1-Year Change
394.74%
Ranking
Category
Stock Price
$3.90
Market Cap Chart
Since December 1, 1998, Dominari Holdings's market cap has increased from $50.00M to $55.91M, an increase of 11.81%. That is a compound annual growth rate of 0.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 25.10M | 304.84% |
| Dec 31, 2024 | 6.20M | -55.07% |
| Dec 29, 2023 | 13.80M | -23.33% |
| Dec 30, 2022 | 18.00M | -65.78% |
| Dec 31, 2021 | 52.60M | 72.46% |
| Dec 31, 2020 | 30.50M | 702.63% |
| Dec 31, 2019 | 3.80M | -30.91% |
| Dec 31, 2018 | 5.50M | -36.78% |
| Dec 29, 2017 | 8.70M | 74.00% |
| Dec 30, 2016 | 5.00M | - |
| Dec 31, 2015 | 5.00M | -83.82% |
| Dec 31, 2014 | 30.90M | 57.65% |
| Dec 31, 2013 | 19.60M | 317.02% |
| Dec 31, 2012 | 4.70M | 30.56% |
| Dec 30, 2011 | 3.60M | -76.32% |
| Dec 31, 2010 | 15.20M | -6.75% |
| Dec 31, 2009 | 16.30M | 146.97% |
| Dec 31, 2008 | 6.60M | -58.23% |
| Dec 31, 2007 | 15.80M | -49.36% |
| Dec 29, 2006 | 31.20M | -25.18% |
| Dec 30, 2005 | 41.70M | 6.11% |
| Dec 31, 2004 | 39.30M | -45.34% |
| Dec 31, 2003 | 71.90M | -18.57% |
| Dec 31, 2002 | 88.30M | -11.26% |
| Dec 31, 2001 | 99.50M | 85.98% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |